Navigation Links
Indications of Alzheimer's disease may be evident decades before first signs of cognitive impairment
Date:3/28/2011

Researchers at Mount Sinai School of Medicine have found that patients with Alzheimer's disease have lower glucose utilization in the brain than those with normal cognitive function, and that those decreased levels may be detectable approximately 20 years prior to the first symptoms of Alzheimer's disease. This new finding could lead to the development of novel therapies to prevent the eventual onset of Alzheimer's. The study is published online in the journal Translational Neuroscience.

Using mice modified to develop Alzheimer's disease, the research team found that when β-amyloid, an abnormal protein linked to Alzheimer's disease, starts to become detectable in the brain in its soluble toxic form, the mitochondria, or "power plants" of the cell where glucose is converted into energy, became impaired. Within the equivalent of about 20 human years, mice with decreased energy metabolism developed signs of Alzheimer's disease such as cognitive defects and impairment of the synaptic terminal, the area of brain cells important in memory formation.

"This evidence in mice validates that the diagnosis of probable Alzheimer's disease may be the end result of impairment in brain cell energy production," said the study's lead author, Giulio M. Pasinetti, MD, PhD, The Saunder Family Professor in Neurology, and Professor of Psychiatry, Geriatrics, and Adult Development at Mount Sinai School of Medicine. "Identifying that mitochondrial impairment is evident years earlier than cognitive defects is a major breakthrough."

"This new evidence could revolutionize the way we design interventions," said Merina T. Varghese, MD, co-author of the study and Postdoctoral Fellow in Neurology at Mount Sinai School of Medicine. "This study sets the stage for the development of potential novel preventions or therapies to apply in humans, even when they have normal cognitive function, to prevent the eventual onset of Alzheimer's disease."


'/>"/>

Contact: Jeanne Bernard
Jeanne.Bernard@MountSinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1

Related medicine news :

1. Early indications of Parkinsons disease revealed in dream sleep
2. Study finds changes in incidence of end-stage renal disease from lupus nephritis
3. Mount Sinai finds promising clue to mechanism behind gene mutation that causes Parkinsons disease
4. Load up on fiber now, avoid heart disease later
5. Study examines whether lower blood pressure reduces kidney disease progression
6. Study Ties Asthma to Higher Odds for Diabetes, Heart Disease
7. Chemistry of Mosquito Sex May Hold Key to Disease Control
8. Doctors should evaluate liver disease patients for cognitive impairment, address driving safety
9. New blood analysis chip could lead to disease diagnosis in minutes
10. Bilingual neurons may reveal the secrets of brain disease
11. Sirolimus therapy alleviates symptoms of lung disease LAM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... January 15, 2017 , ... The JPR Group, a ... announce that it will be assisting HackensackUMC Mountainside with its public relations efforts, ... servicing all surrounding towns. The firm will be working closely with HackensackUMC Mountainside’s ...
(Date:1/14/2017)... ... January 14, 2017 , ... AgileMinder develops innovative products and services that ... is now available on Apple as a fun, free emoji sticker pack for iMessage. ... of the ten color coded values on The Emoji Scale. , On Apple: ...
(Date:1/13/2017)... ... , ... The 18th European Congress: Perspectives in Lung Cancer will be held ... Congress is expertly designed to meet the educational needs of European oncology clinicians and ... by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University of Torino, and ...
(Date:1/13/2017)... ... January 13, 2017 , ... With the ... the challenge of providing additional organic alternatives for customers who have grown more ... brand’s new line of all-natural activated charcoal products, Moody Zook Chief Executive Officer ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive ... of pain whenever they brush their teeth. Sadly, most dental hygiene products in the ... gums and teeth. For these people, continuing their daily oral care routine to keep ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... Bill is an internationally experienced medical device industry executive who has ... medical device companies, including Smith & Nephew, Angiodynamics, Orthovita and Stryker. ... building successful businesses in the sector and has worked in ... North America . ... Educated at the University of Edinburgh (Dental Surgery), University ...
(Date:1/16/2017)... Tenn. , Jan. 16, 2017  Cumberland Pharmaceuticals ... of Kenneth J. Krogulski , CFA to its ... Executive Officer of Berkshire Asset Management LLC . ... a 30-year-old independent SEC registered investment advisory firm with ... has over 37 years, experience in security analysis and ...
(Date:1/15/2017)... 14, 2017 ImmersiveTouch Inc., the global leader ... announced recent appointments strengthening their Executive Management team.  ... as Chief Executive Officer, Jay Banerjee as ... President of Sales and Jia Luo , PhD ... Mr. Bowman has 20 years experience commercializing ...
Breaking Medicine Technology: